OverviewChartNewsTraderScreen

FUJI CORP./  JP3809200003  /

Frankfurt
5/28/2024  10:30:02 AM Chg. 0.0000 Volume Bid10:30:02 AM Ask10:30:02 AM High Low
14.4000EUR 0.00% 0
Turnover: 0.0000		 14.4000Bid Size: 150 15.3000Ask Size: 140 14.5000 14.4000
TeleTrader 5/24 Mitsubishi Electric announces Vietnamese JV
GlobeNewswire 5/21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 5/21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...
GlobeNewswire 5/21 Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire 5/16 Blue World Acquisition Corporation Announces the Redemption Deadline as May 23, 2024 for the Extraor...
GlobeNewswire 5/13 Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...
GlobeNewswire 5/2 Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
GlobeNewswire 4/30 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire 4/24 Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...
GlobeNewswire 4/19 Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire 4/16 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire 4/15 Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Busin...
GlobeNewswire 4/3 Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
GlobeNewswire 4/3 Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combi...
GlobeNewswire 3/22 Alvotech Announces Increase in Number of Own Shares
GlobeNewswire 3/20 Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
GlobeNewswire 3/14 Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire 3/5 Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
GlobeNewswire 3/4 Terrata Homes Expands Presence with A New Community in Seattle
GlobeNewswire 2/29 Alvotech Appoints Interim Chief Quality Officer
GlobeNewswire 2/29 Golar LNG Limited preliminary fourth quarter and financial year 2023 results
GlobeNewswire 2/26 Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purc...
GlobeNewswire 2/24 Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interc...
GlobeNewswire 2/20 Official 24 Hours of Le Mans Game, Le Mans Ultimate, available today
GlobeNewswire 2/15 Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)